Protocol for CRISPR-Cas9 gene editing of murine neutrophils for in vitro and in vivo mechanistic studies

Neutrophils’ short lifespan and resistance to genetic manipulation have limited mechanistic interrogation of gene-specific functions in these cells. Here, we present a protocol for gene targeting in murine neutrophil-lineage cells using two complementary CRISPR-Cas9-based strategies. First, we describe steps for an ER-Hoxb8-based system for scalable gain- and loss-of-function studies. We then detail procedures for a Lineage− Sca-1+ cKit+ (LSK) progenitor cell-based hematopoietic stem and progenitor cell-targeting strategy for stable genetic perturbation of endogenous neutrophils. For complete information on the generation and use of this protocol, please refer to Bolli et al. 1 1. Bolli, E. ∙ Wirapati, P. ∙ Hicham, M. ... CCL3 is produced by aged neutrophils across cancers and promotes tumor growth Cancer Cell. 2026; 44 :624-640.e12 Full Text Full Text (PDF) Scopus (8) PubMed Google Scholar

Authors

Institutions

Publication Details

Journal
STAR Protocols
Published
2026-11-16
DOI
https://doi.org/10.1016/j.xpro.2026.104952
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Protocol for CRISPR-Cas9 gene editing of murine neutrophils for in vitro and in vivo mechanistic studies

Evangelia Bolli, Mikäel J. Pittet, Camilla Engblom, Marie Siwicki et al.
2 links
STAR Protocols
CRISPR and Genetic Engineering
article

Protocol for CRISPR-Cas9 gene editing of murine neutrophils for in vitro and in vivo mechanistic studies

Evangelia Bolli, Mikäel J. Pittet, Camilla Engblom, Marie Siwicki, Robert Manguso
article en

Abstract

Neutrophils’ short lifespan and resistance to genetic manipulation have limited mechanistic interrogation of gene-specific functions in these cells. Here, we present a protocol for gene targeting in murine neutrophil-lineage cells using two complementary CRISPR-Cas9-based strategies. First, we describe steps for an ER-Hoxb8-based system for scalable gain- and loss-of-function studies. We then detail procedures for a Lineage− Sca-1+ cKit+ (LSK) progenitor cell-based hematopoietic stem and progenitor cell-targeting strategy for stable genetic perturbation of endogenous neutrophils. For complete information on the generation and use of this protocol, please refer to Bolli et al. 1 1. Bolli, E. ∙ Wirapati, P. ∙ Hicham, M. ... CCL3 is produced by aged neutrophils across cancers and promotes tumor growth Cancer Cell. 2026; 44 :624-640.e12 Full Text Full Text (PDF) Scopus (8) PubMed Google Scholar

STAR ProtocolsVol. 7(4)
Broad Institute (US), University of Geneva (CH), Karolinska University Hospital (SE), Harvard University (US), University of Calgary (CA), Science for Life Laboratory (SE), Karolinska Institutet (SE), Massachusetts General Hospital (US), University Hospital of Geneva (CH), Ludwig Cancer Research (CH), Swiss Cancer Center Léman (CH), Massachusetts Institute of Technology (US)
Damon Runyon Cancer Research Foundation, Belgian American Educational Foundation, Ludwig Institute for Cancer Research, European Commission, Fondation ISREC
Good health and well-being
CRISPR and Genetic Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon